Ricci, F., Fratelli, M., Guffanti, F., Porcu, L., Spriano, F., Dell’Anna, T., . . . Damia, G. (2016). Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: A new experimental setting to study response to therapy. Oncotarget.
Chicago Style CitationRicci, Francesca, Maddalena Fratelli, Federica Guffanti, Luca Porcu, Filippo Spriano, Tiziana Dell’Anna, Robert Fruscio, i Giovanna Damia. "Patient-derived Ovarian Cancer Xenografts Re-growing After a Cisplatinum Treatment Are Less Responsive to a Second Drug Re-challenge: A New Experimental Setting to Study Response to Therapy." Oncotarget 2016.
Cita MLARicci, Francesca, et al. "Patient-derived Ovarian Cancer Xenografts Re-growing After a Cisplatinum Treatment Are Less Responsive to a Second Drug Re-challenge: A New Experimental Setting to Study Response to Therapy." Oncotarget 2016.